Project Summary

This project uses the CaP-lipid-based nanoparticle to deliver therapeutic agents (such as siRNAs, growth factors, cytokines, and/or drugs) to target cells, tumours or tumour microenvironment, leading to the regression or even the elimination of solid tumours. 

CaP nanoparticle-based lipid-encapsulated system for target delivery of anti-tumour therapeutics

Research Group

Xu Group


Nanomaterials, Nanobiotechnology, Health, Target delivery, Tumour, Nanoparticle, Tumor Microenvironment, RNAi, Cytokines, Anti-tumour Therapeutics

Available Student Projects

CaP nanoparticle-based encapsulated system for target drug delivery


Project members

Project Lead

Professor Zhi Ping (Gordon) Xu

Senior Group Leader
Xu Group

Researcher Involved

Dr Jie Tang

NHMRC Emerging Leadership Fellow
Yu Group